AI assistant
Sending…
Innoviva, Inc. — Director's Dealing 2015
Jul 15, 2015
32090_dirs_2015-07-15_95bc4a6e-ec13-4a2b-af32-5ecf03ac9a40.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2015-07-14
Reporting Person: Faerm Michael E. (Sr VP & Chief Business Officer)
More from Innoviva, Inc.
Board/Management Information
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 4
Major Shareholding Notification
2026
Mar 27
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2025
Nov 24